8-K: Teladoc Health Q3 2025: Revenue Down, Net Loss Widens

Teladoc Health reported a 2% year-over-year revenue decrease and a widened net loss of $49.5 million for Q3 2025, though results were in the upper half of guidance.

Summary

• Consolidated revenue for Q3 2025 was $626.4 million, a 2% decrease year-over-year from $640.5 million in Q3 2024.
• Net loss for Q3 2025 totaled $49.5 million, or $0.28 per share, compared to a net loss of $33.3 million, or $0.19 per share, in Q3 2024.
• Adjusted EBITDA for Q3 2025 was $69.9 million, a 16% decrease year-over-year from $83.3 million in Q3 2024.
• Integrated Care segment revenue increased 2% year-over-year to $389.5 million in Q3 2025, with an adjusted EBITDA margin of 17.0%.
• BetterHelp segment revenue decreased 8% year-over-year to $236.9 million in Q3 2025, with an adjusted EBITDA margin of 1.6%.
• U.S. revenue decreased 5% to $509.8 million, while International revenue increased 12% to $116.7 million in Q3 2025.
• Results for Q3 2025 included a non-cash goodwill impairment charge of $12.6 million, or $0.07 per share pre-tax, related to the acquisition of Telecare Australia Pty Ltd within the Integrated Care segment.
• For the first nine months of 2025, revenue decreased 2% to $1,887.7 million, and net loss totaled $175.2 million, or $1.00 per share, a significant improvement from a $952.8 million net loss, or $5.61 per share, in the first nine months of 2024.
• Cash flow from operations was $99.3 million in Q3 2025, down from $110.2 million in Q3 2024.
• Free cash flow was $67.9 million in Q3 2025, down from $79.0 million in Q3 2024.

Sentiment

Score: 5

Explanation: While Q3 2025 showed a year-over-year decline in consolidated revenue and a widened net loss, the company reported results in the upper half of its guidance ranges, indicating execution within expectations. The significant improvement in the nine-month net loss compared to the prior year, largely due to reduced goodwill impairment charges, is a positive. However, the substantial decline in the BetterHelp segment's revenue and adjusted EBITDA remains a key concern, partially offset by modest growth in the Integrated Care segment and international revenue. The outlook suggests continued efforts to stabilize performance.

Positives

• Consolidated revenues and adjusted EBITDA for Q3 2025 were in the upper half of the company's guidance ranges.
• Integrated Care segment revenue increased 2% year-over-year to $389.5 million in Q3 2025.
• International revenue increased 12% year-over-year to $116.7 million in Q3 2025.
• Net loss for the first nine months of 2025 significantly improved to $175.2 million ($1.00 per share) from $952.8 million ($5.61 per share) in the first nine months of 2024, primarily due to a much lower goodwill impairment charge.
• U.S. Integrated Care Members increased 9% to 102.5 million as of September 30, 2025.

Negatives

• Consolidated revenue decreased 2% year-over-year to $626.4 million in Q3 2025.
• Net loss widened to $49.5 million in Q3 2025 from $33.3 million in Q3 2024.
• Adjusted EBITDA decreased 16% year-over-year to $69.9 million in Q3 2025.
• BetterHelp segment revenue decreased 8% year-over-year to $236.9 million in Q3 2025.
• BetterHelp segment adjusted EBITDA decreased 75% year-over-year to $3.8 million in Q3 2025.
• U.S. revenue decreased 5% year-over-year to $509.8 million in Q3 2025.
• Access fees revenue decreased 6% year-over-year to $520.9 million in Q3 2025.
• Average Monthly Revenue Per U.S. Integrated Care Member decreased 7% to $1.27 in Q3 2025.
• BetterHelp Paying Users decreased 4% to 0.382 million in Q3 2025.
• A non-cash goodwill impairment charge of $12.6 million was recorded in Q3 2025 related to the Integrated Care segment.

Risks

• Changes in laws and regulations applicable to the business model.
• Changes in market conditions and receptivity to services and offerings, including the ability to effectively compete.
• Results of litigation or regulatory actions.
• The loss of one or more key clients or the loss of a significant number of members or BetterHelp paying users.
• Changes in valuations or useful lives of assets.
• Changes to the ability to recruit and retain qualified providers into the network.
• The impact of and risk related to impairment losses with respect to goodwill or other assets.
• The success of initiatives to improve efficiency and competitiveness.
• Imposed and threatened tariffs by the United States and its trading partners, and any resulting disruptions or inefficiencies in the supply chain.

Future Outlook

For the full year 2025, Teladoc Health expects revenue between $2,510 million and $2,539 million, adjusted EBITDA between $270 million and $287 million, and a net loss per share between ($1.25) and ($1.10). Free cash flow is projected to be $170 million to $185 million, with U.S. Integrated Care Members expected to be 101.5 million to 102.5 million. For the fourth quarter of 2025, revenue is projected between $622 million and $652 million, and adjusted EBITDA between $73 million and $90 million.

Management Comments

• "In the third quarter, we again delivered consolidated revenues and adjusted EBITDA in the upper half of our guidance ranges, reflecting consistent execution along with our steadfast commitment to serving our clients and members."
• "Looking ahead we remain focused on advancing important work across each of our strategic priorities, including growth initiatives to drive greater value and impact within our Integrated Care segment and the ongoing rollout of insurance acceptance in BetterHelp."

Industry Context

The virtual care industry continues to evolve, with companies like Teladoc Health navigating shifts in consumer behavior, regulatory landscapes, and competitive pressures. The mixed results, with modest growth in Integrated Care but declines in BetterHelp, suggest a divergence in demand across different virtual health services. This could reflect increased competition in direct-to-consumer mental health or a maturation of that market segment, while enterprise-focused integrated care shows resilience. The strategic focus on "insurance acceptance in BetterHelp" indicates an effort to broaden access and potentially stabilize revenue in that segment amidst these dynamics.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: Mixed results with revenue decline and widened net loss, but meeting guidance. Future outlook suggests continued challenges but also strategic focus. Goodwill impairment indicates potential asset value concerns.
• Customers/Members: Continued service delivery with growth in U.S. Integrated Care Members, but a decrease in BetterHelp Paying Users. Rollout of insurance acceptance in BetterHelp aims to improve access.
• Employees: Restructuring costs related to severance and office space reductions indicate ongoing operational adjustments.

Next Steps

• Advancing growth initiatives to drive greater value and impact within the Integrated Care segment.
• Ongoing rollout of insurance acceptance in BetterHelp.
• A replay of the Q3 2025 earnings call will be available via webcast for approximately 90 days.

Key Dates

Recommendation

While Teladoc Health met its Q3 guidance, the underlying financial trends show a decline in overall revenue and profitability, particularly in the BetterHelp segment. The growth in Integrated Care and international markets provides some offset, but the company faces significant headwinds, including competitive pressures and the need to stabilize its direct-to-consumer offerings. The goodwill impairment charge, though smaller than the previous year, still highlights valuation challenges. The stock is likely to remain volatile as the company executes its strategic priorities, making a "hold" recommendation appropriate for investors awaiting clearer signs of sustainable growth and improved profitability across all segments.

Keywords

Teladoc Health, TDOC, virtual care, telehealth, digital health, Q3 2025 earnings, financial results, Integrated Care, BetterHelp, mental health, chronic care management, adjusted EBITDA, net loss, revenue